LOGIN
Shockwave Therapy vs. Corticosteroid Injection for Greater Trochanteric Pain Syndrome
July 2023
Shockwave Therapy vs. Corticosteroid Injection for Greater Trochanteric Pain Syndrome
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Greater trochanteric pain syndrome: focused shockwave therapy versus an ultrasound guided injection: a randomised control trial.
Hip Int. 2023 May;33(3):490-499.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
104 patients with greater trochanteric pain syndrome were randomized to receive an injection of corticosteroid (n=51) or 3 weekly sessions of focused extracorporeal shockwave therapy (f-ESWT; n=53). The primary outcome of interest was pain on a Visual Analog Scale (VAS). Secondary outcomes of interest included the Harris Hip Score (HHS), the Trendelenberg test for function, quality of life on the ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.